Literature DB >> 4234077

The role of immune complexes and complement in tissue injury.

C G Cochrane.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 4234077     DOI: 10.1016/0021-8707(68)90085-3

Source DB:  PubMed          Journal:  J Allergy        ISSN: 0021-8707


× No keyword cloud information.
  10 in total

1.  Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.

Authors:  B Dodman; W J Cunliffe; B E Roberts; R Sibbald
Journal:  Br Med J       Date:  1973-04-14

2.  Pathology, pathogenesis, and aetiology of rheumatoid arthritis.

Authors:  L E Glynn
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

3.  [Significance of immunohistological findings for the diagnosis of kidney diseases].

Authors:  H Asamer; P Dittrich; B Lederer
Journal:  Klin Wochenschr       Date:  1969-07-15

4.  [Influence of Cu-chlorophylline on Masugi nephritis].

Authors:  M Frimmer; D Hegner; B Schischke; B Schnorr
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

5.  Anti-IgA antibodies in rheumatic and pulmonary disease.

Authors:  R C Eggert; D J Brauer; E M Caperton
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

6.  Complement-fixing activity of rheumatoid synovial fluid.

Authors:  A S Townes; R L Marcus
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

7.  Fibrinolysis in cutaneous vasculitis.

Authors:  W J Cunliffe
Journal:  Proc R Soc Med       Date:  1971-09

8.  [The effect of heparin and prednisolone on experimental glomerunephritis].

Authors:  G Schütterle; D Platt
Journal:  Klin Wochenschr       Date:  1970-02-01

Review 9.  [The kidney and hemostasis].

Authors:  H G Lasch; G Schütterle
Journal:  Klin Wochenschr       Date:  1970-09-01

10.  Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes.

Authors:  K J Gajl-Peczalska; A J Fish; H J Meuwissen; D Frommel; R A Good
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.